Nombre del producto:5-methoxy-2,3-dihydro-1H-inden-1-amine
IUPAC Name:5-methoxy-2,3-dihydro-1H-inden-1-amine
| Unidad de embalaje | Stock disponible | Precio($) | Cantidad |
|---|---|---|---|
| CM193672-1g | 3-4 Weeks | ůƓʼn |
|
|
|||
| Product Overview |
5-methoxy-2,3-dihydro-1H-inden-1-amine, also known as 5-MeO-DBT, is a psychoactive compound that belongs to the class of tryptamines. It is a synthetic derivative of the natural compound bufotenin, which is found in certain species of toads and mushrooms. |
| Synthesis Method |
The synthesis of 5-methoxy-2,3-dihydro-1H-inden-1-amine involves the reaction of bufotenin with 2,3-dihydrofuran in the presence of a Lewis acid catalyst. The resulting product is then reduced using sodium borohydride to yield 5-methoxy-2,3-dihydro-1H-inden-1-amine. |
| Chemical Properties |
It is a relatively stable compound that can be easily synthesized in large quantities. |
| Synthesis and Application |
Studies have shown that 5-methoxy-2,3-dihydro-1H-inden-1-amine has antidepressant and anxiolytic effects in animal models. Additionally, it has been found to enhance neurogenesis, which is the growth and development of new neurons in the brain. This suggests that 5-methoxy-2,3-dihydro-1H-inden-1-amine may have potential as a treatment for neurodegenerative disorders such as Alzheimer's disease. |
| Future Directions |
One area of interest is its potential as a treatment for depression and anxiety. Further studies are needed to better understand its mechanism of action and to determine optimal dosing and administration methods. Another area of research is the potential use of 5-methoxy-2,3-dihydro-1H-inden-1-amine in the treatment of neurodegenerative disorders such as Alzheimer's disease. Studies have shown that it can enhance neurogenesis, which may have therapeutic implications for these conditions. Finally, there is interest in exploring the use of 5-methoxy-2,3-dihydro-1H-inden-1-amine in combination with other psychoactive compounds, such as psilocybin and LSD, for the treatment of mental health disorders. These compounds have been shown to have complementary effects on the brain and may have synergistic therapeutic benefits when used together. |
Buscar 
+86 21 5895 0110 
